(-)-demecolcine increases expression ISO RGD:1343434 6480464 Demecolcine results in increased expression of PLA1A mRNA CTD PMID:23649840 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PLA1A mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1332024 6480464 Estradiol results in increased expression of PLA1A mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA1A mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332024 6480464 Tetrachlorodibenzodioxin affects the expression of PLA1A mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332024 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA1A mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332024 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLA1A mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1343434 6480464 Tetrachlorodibenzodioxin affects the expression of PLA1A mRNA CTD PMID:22298810 6alpha-methylprednisolone multiple interactions ISO RGD:1343434 6480464 Methylprednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 aflatoxin B1 affects expression ISO RGD:1343434 6480464 Aflatoxin B1 affects the expression of PLA1A protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PLA1A mRNA CTD PMID:25378103 aflatoxin B1 increases expression ISO RGD:1343434 6480464 Aflatoxin B1 results in increased expression of PLA1A mRNA CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1332024 6480464 Aflatoxin B1 results in increased expression of PLA1A mRNA CTD PMID:19770486 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PLA1A mRNA CTD PMID:16483693 Aroclor 1254 multiple interactions ISO RGD:1332024 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in decreased expression of PLA1A mRNA CTD PMID:23804495 arsenite(3-) affects expression ISO RGD:1343434 6480464 arsenite affects the expression of PLA1A mRNA CTD PMID:22959463 azithromycin increases activity EXP 6480464 Azithromycin results in increased activity of PLA1A protein CTD PMID:8830663 beclomethasone multiple interactions ISO RGD:1343434 6480464 Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 benzo[a]pyrene decreases expression ISO RGD:1332024 6480464 Benzo(a)pyrene results in decreased expression of PLA1A mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1343434 6480464 Benzo(a)pyrene affects the methylation of PLA1A intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1332024 6480464 Benzo(a)pyrene results in increased expression of PLA1A mRNA CTD PMID:21569818 , PMID:23735875 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLA1A mRNA CTD PMID:18164116 bilirubin IXalpha decreases expression ISO RGD:1343434 6480464 Bilirubin results in decreased expression of PLA1A mRNA CTD PMID:20196124 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1332024 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in decreased expression of PLA1A mRNA CTD PMID:23804495 bisphenol A increases expression ISO RGD:1332024 6480464 bisphenol A results in increased expression of PLA1A mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLA1A mRNA CTD PMID:25181051 buta-1,3-diene increases expression ISO RGD:1332024 6480464 1, 3-butadiene results in increased expression of PLA1A mRNA CTD PMID:29038090 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PLA1A mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO RGD:1332024 6480464 Nanotubes, Carbon results in decreased expression of PLA1A mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1332024 6480464 Nanotubes, Carbon analog results in increased expression of PLA1A mRNA, Nanotubes, Carbon results in increased expression of PLA1A mRNA CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of PLA1A mRNA CTD PMID:19395590 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of PLA1A mRNA CTD PMID:18500788 cisplatin multiple interactions ISO RGD:1343434 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PLA1A mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:1332024 6480464 Clofibrate results in decreased expression of PLA1A mRNA CTD PMID:25270620 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PLA1A mRNA CTD PMID:24386269 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of PLA1A mRNA CTD PMID:15755911 cyclosporin A increases expression ISO RGD:1343434 6480464 Cyclosporine results in increased expression of PLA1A mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:1332024 6480464 Cyclosporine results in decreased expression of PLA1A mRNA CTD PMID:19770486 dexamethasone multiple interactions ISO RGD:1343434 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PLA1A mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1332024 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA1A mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLA1A mRNA CTD PMID:25152437 ethyl methanesulfonate increases expression ISO RGD:1343434 6480464 Ethyl Methanesulfonate results in increased expression of PLA1A mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:1343434 6480464 Fenofibrate results in increased expression of PLA1A mRNA CTD PMID:25572481 formaldehyde increases expression ISO RGD:1343434 6480464 Formaldehyde results in increased expression of PLA1A mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of PLA1A mRNA CTD PMID:25539665 gentamycin decreases activity EXP 6480464 Gentamicins results in decreased activity of PLA1A protein CTD PMID:8830663 glafenine increases expression EXP 6480464 Glafenine results in increased expression of PLA1A mRNA CTD PMID:24136188 glycidol increases expression EXP 6480464 glycidol results in increased expression of PLA1A mRNA CTD PMID:24915197 GW 4064 increases expression ISO RGD:1332024 6480464 GW 4064 results in increased expression of PLA1A mRNA CTD PMID:26655953 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of PLA1A mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:1343434 6480464 Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] more ... CTD PMID:20573295 lipopolysaccharide increases expression ISO RGD:1332024 6480464 Lipopolysaccharides results in increased expression of PLA1A mRNA CTD PMID:17321000 lipopolysaccharide increases expression ISO RGD:1343434 6480464 Lipopolysaccharides results in increased expression of PLA1A mRNA CTD PMID:20573295 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of PLA1A mRNA CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PLA1A mRNA CTD PMID:19564919 methotrexate multiple interactions ISO RGD:1343434 6480464 Methotrexate inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 N-nitrosodiethylamine increases expression ISO RGD:1332024 6480464 Diethylnitrosamine results in increased expression of PLA1A mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLA1A mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of PLA1A mRNA CTD PMID:18164116 , PMID:28943392 N-nitrosodiethylamine multiple interactions ISO RGD:1332024 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLA1A mRNA] CTD PMID:17942915 naphthalene increases expression ISO RGD:1332024 6480464 naphthalene results in increased expression of PLA1A mRNA CTD PMID:18978301 nickel atom increases expression ISO RGD:1343434 6480464 Nickel results in increased expression of PLA1A mRNA CTD PMID:24768652 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLA1A mRNA CTD PMID:25729387 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of PLA1A mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:1332024 6480464 Acetaminophen affects the expression of PLA1A mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1343434 6480464 Acetaminophen results in decreased expression of PLA1A mRNA CTD PMID:29067470 perfluorooctanoic acid decreases expression ISO RGD:1332024 6480464 perfluorooctanoic acid results in decreased expression of PLA1A mRNA CTD PMID:17681415 pirinixic acid multiple interactions ISO RGD:1332024 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLA1A mRNA, PPARA protein affects the reaction [pirinixic acid results in decreased expression of PLA1A mRNA] CTD PMID:17321000 , PMID:19710929 pirinixic acid decreases expression ISO RGD:1332024 6480464 pirinixic acid results in decreased expression of PLA1A mRNA CTD PMID:17321000 more ... prednisolone multiple interactions ISO RGD:1343434 6480464 Prednisolone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PLA1A mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:1332024 6480464 propiconazole results in decreased expression of PLA1A mRNA CTD PMID:21278054 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PLA1A mRNA CTD PMID:28374803 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of PLA1A mRNA CTD PMID:19564919 silicon dioxide decreases expression ISO RGD:1343434 6480464 Silicon Dioxide analog results in decreased expression of PLA1A mRNA CTD PMID:25895662 sodium arsenite affects expression ISO RGD:1343434 6480464 sodium arsenite affects the expression of PLA1A mRNA CTD PMID:29319823 sodium arsenite increases expression ISO RGD:1343434 6480464 sodium arsenite results in increased expression of PLA1A mRNA CTD PMID:29301061 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PLA1A mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of PLA1A mRNA CTD PMID:19281266 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of PLA1A mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:1332024 6480464 Carbon Tetrachloride affects the expression of PLA1A mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PLA1A mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1332024 6480464 Carbon Tetrachloride results in decreased expression of PLA1A mRNA CTD PMID:27339419 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of PLA1A mRNA CTD PMID:28943392 titanium dioxide increases expression ISO RGD:1332024 6480464 titanium dioxide results in increased expression of PLA1A mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PLA1A mRNA CTD PMID:25729387 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of PLA1A mRNA CTD PMID:21515302 troglitazone increases expression ISO RGD:1332024 6480464 troglitazone results in increased expression of PLA1A mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1332024 6480464 Valproic Acid affects the expression of PLA1A mRNA CTD PMID:17963808 valproic acid decreases methylation ISO RGD:1343434 6480464 Valproic Acid results in decreased methylation of PLA1A gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PLA1A mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:1343434 6480464 Vincristine results in increased expression of PLA1A mRNA CTD PMID:23649840 zoledronic acid increases expression ISO RGD:1343434 6480464 zoledronic acid results in increased expression of PLA1A mRNA CTD PMID:24714768 
Gene Ontology Annotations
